Kyn Therapeutics

Biotech IPO market looks to ramp back up as BMS partner Ikena and its immunometabolism therapies eye public offering
Endpoints
Mon, 03/8/21 - 09:15 pm
IPOs
Ikena Oncology
Kyn Therapeutics
NASDAQ